Clinical trial
Cross-sectional Evaluation of Psychiatric Population With DELPhI- Characterization of Psychiatric Conditions
NCT03842345 is registered in ClinicalTrials.gov with QuantalX Neuroscience as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross-sectional Evaluation of Psychiatric Population With DELPhI- Characterization of Psychiatric Conditions
- Lead sponsor
- QuantalX Neuroscience
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- March 31, 2020
- Completion date
- February 28, 2021
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adhd, bi-polar disorder, healthy, major depressive disorder, ocd, ptsd, schizophrenia